Lithium is unlikely to cause liver damage. The National Institute of Diabetes and Digestive and Kidney Diseases gives lithium a likelihood score of “E” for causing clinically apparent liver injury, which is the lowest risk category. While a small number of people on lithium may see mild changes on liver blood tests, these elevations have not been convincingly linked to actual liver disease.
Why Lithium Largely Bypasses the Liver
Most medications are broken down by the liver before being cleared from the body, which is why so many drugs carry hepatotoxicity warnings. Lithium works differently. It undergoes no metabolic transformation in the body at all. It circulates in its original form and is excreted entirely through the kidneys. Because the liver doesn’t have to process or convert lithium into other compounds, there’s very little opportunity for it to cause the kind of cellular stress that leads to liver injury.
This is also why kidney health, not liver health, is the primary monitoring concern with long-term lithium use. About 80% of excreted lithium is reabsorbed in the kidneys, which means those organs do substantial work managing the drug over time.
What the Liver Test Changes Actually Mean
A small proportion of people on long-term lithium therapy will show mild elevations in liver enzymes (the markers doctors check on routine blood panels). These elevations tend to be modest and don’t progress to symptomatic liver problems. There are no well-documented cases convincingly linking lithium to acute liver injury, liver failure, jaundice, or cirrhosis.
Mild enzyme bumps can happen with many medications and often reflect minor, temporary stress on liver cells rather than meaningful damage. If your doctor orders liver panels while you’re on lithium, it’s typically part of a general health check rather than a specific concern about the drug harming your liver.
How Lithium Affects Bile Production
One area where lithium does interact with the liver involves bile acids, the compounds your liver produces to help digest fats. Animal research has shown that lithium disrupts a signaling pathway in the liver that normally keeps bile production in check. The result is increased bile acid levels throughout the body. Valproate, another common mood stabilizer, has a similar effect.
This finding comes from rat studies and its clinical significance in humans isn’t fully clear. But it does show that lithium isn’t completely inert when it comes to liver function. It also has an interesting effect on how liver cells store energy: in diabetic rats, lithium stimulated glycogen synthesis (the process of converting glucose into stored fuel) in a way that resembled insulin’s effects, though through a different mechanism.
How Lithium Compares to Other Mood Stabilizers
If you’re weighing lithium against alternatives, its liver safety profile is notably better than some other options. Valproate, one of the most commonly prescribed mood stabilizers, carries well-established risks of liver toxicity, including rare but serious cases of liver failure. Carbamazepine also has documented hepatotoxic potential. Lithium’s “unlikely” rating for liver injury makes it one of the safer choices from a hepatic standpoint.
That said, lithium’s main organ-level risks fall on the kidneys and thyroid. Long-term use can reduce kidney function over time, and it frequently affects thyroid hormone production. These are the systems your prescriber will monitor most closely with periodic blood work.
When Liver Concerns Might Still Matter
If you already have liver disease, the good news is that lithium doesn’t depend on the liver for processing, so pre-existing liver conditions don’t typically change how the drug is handled in your body. This is different from medications that require dose adjustments in people with compromised liver function.
The more relevant concern is what else you’re taking alongside lithium. Many people on mood stabilizers also take other psychiatric medications, pain relievers, or supplements that do stress the liver. If you notice unusual fatigue, dark urine, or yellowing of the skin while on any medication regimen, those symptoms warrant attention regardless of which specific drug might be responsible.